GI Dynamics is a medical device company developing therapies for the treatment of type 2 diabetes and related metabolic diseases.
GI Dynamics, Inc., a medical device company, develops therapies for the treatment of type 2 diabetes and related metabolic diseases in the United States. Its products also include EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. The company was founded in 2003 and is based in Lexington, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 23, 2019 | Post-IPO Equity | $10M | 1 | Crystal Amber | — | Detail |
Jan 7, 2010 | Series Unknown | $15M | 1 | Medtronic | — | Detail |
Mar 2, 2009 | Series C | $15M | 2 | — | — | Detail |
May 25, 2004 | Series B | $12M | 2 | Cutlass Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Crystal Amber | Yes | Post-IPO Equity |
Medtronic | Yes | Series Unknown |
Seedling Enterprises | — | Series C |
Cutlass Capital | — | Series C |